Kurz P, Tsobanelis T, Roth P, Werner E, Ewald U, Grützmacher P, Schoeppe W, Vlachojannis J
St. Markus Hospital, Frankfurt/M, Germany.
Clin Nephrol. 1995 Oct;44(4):255-61.
To assess the effect of different dialysis modalities on calcium turnover, we studied 57 patients on maintenance hemodialysis treatment (HD) and 38 patients on continuous ambulatory peritoneal dialysis (CAPD) with tracer kinetic studies using two calcium isotopes (45Ca by mouth and 47Ca intravenously). The two groups were comparable in age, sex and prevalence of diabetes. The groups did not differ in their serum concentrations of intact parathyroid hormone (iPTH), calcium, inorganic phosphate and 1,25-dihydroxyvitamin D. 25-hydroxy-vitamin D and alkaline phosphatase were found to be significantly higher in HD patients. Despite these similarities, CAPD patients showed a significantly lower calcium kinetic response as measured by calcium retention and plasma calcium efflux than HD patients. Mean calcium retention was 39.5% in HD patients compared to 31.2% in the CAPD group (p < 0.05). Plasma calcium efflux was significantly lower in the CAPD group (2.7 vs 3.2 respectively; p < 0.01). iPTH correlated with calcium retention and plasma calcium efflux in HD patients (r = 0.69 and r = 0.67 respectively). In CAPD patients, the correlation coefficient between iPTH and calcium retention was markedly lower (r = 0.54), whereas no correlation was found between iPTH and plasma calcium efflux (r = 0.08). In addition, the slope of the correlation curve were higher in HD patients (p < 0.01 and p < 0.001, respectively), indicating a better response of this patient group to the action of parathyroid hormone. Our data are in accordance with recently published results showing that the dialysis modality has a major impact on bone turnover and on the progression of uremic bone disease. It has been shown that CAPD is an independent risk factor for the development of the adynamic form of renal bone disease. This finding may be explained by the lower response of calcium turnover to the action of PTH as shown here with tracer kinetic studies.
为评估不同透析方式对钙周转的影响,我们采用两种钙同位素(口服45Ca和静脉注射47Ca)的示踪动力学研究方法,对57例维持性血液透析(HD)患者和38例持续性非卧床腹膜透析(CAPD)患者进行了研究。两组患者在年龄、性别和糖尿病患病率方面具有可比性。两组患者的血清完整甲状旁腺激素(iPTH)、钙、无机磷和1,25 - 二羟维生素D浓度无差异。发现HD患者的25 - 羟维生素D和碱性磷酸酶显著更高。尽管存在这些相似之处,但通过钙潴留和血浆钙外流测量,CAPD患者的钙动力学反应显著低于HD患者。HD患者的平均钙潴留为39.5%,而CAPD组为31.2%(p < 0.05)。CAPD组的血浆钙外流显著更低(分别为2.7和3.2;p < 0.01)。HD患者中iPTH与钙潴留和血浆钙外流相关(r分别为0.69和0.67)。在CAPD患者中,iPTH与钙潴留之间的相关系数明显更低(r = 0.54),而iPTH与血浆钙外流之间未发现相关性(r = 0.08)。此外,HD患者的相关曲线斜率更高(分别为p < 0.01和p < 0.001),表明该患者组对甲状旁腺激素作用的反应更好。我们的数据与最近发表的结果一致,表明透析方式对骨转换和尿毒症骨病的进展有重大影响。已表明CAPD是肾性骨病动力缺乏型发展的独立危险因素。这一发现可能可以用此处示踪动力学研究所示的钙周转对PTH作用的较低反应来解释。